Diabetes

Orforglipron pills could offer a new option for stabilising weight changes after injectable GLP-1 therapy, according to the ATTAIN-MAINTAIN trial.

Researchers have called for increased awareness, education, and safe spaces for children in the UK with Type 1 diabetes, following investigation into diabetes technology access.

Insulin resistance is independently linked to MASLD in type 1 diabetes, highlighting a distinct high-risk metabolic phenotype in affected patients.

Semaglutide might offer a novel treatment pathway for alcohol use disorder in those with comorbid obesity. Learn more.

Semaglutide improved motivation in patients with major depressive disorder, holding promise for the treatment of neuropsychiatric disorders characterised by reward dysfunction.

MRI Pacinian corpuscles in the forefoot may reflect diabetic sensorimotor polyneuropathy severity, with counts correlating to nerve conduction measures.

A meta-analysis found SGLT2 inhibitors reduced rejection risk after heart transplantation in patients with diabetes, while other major outcomes remained unchanged.

Indigenous populations historically face a significantly higher prevalence of Type 2 diabetes than global averages, a new systematic review has found.